1. Home
  2. VTYX vs TAYD Comparison

VTYX vs TAYD Comparison

Compare VTYX & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • TAYD
  • Stock Information
  • Founded
  • VTYX 2018
  • TAYD 1955
  • Country
  • VTYX United States
  • TAYD United States
  • Employees
  • VTYX N/A
  • TAYD N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • TAYD Industrial Machinery/Components
  • Sector
  • VTYX Health Care
  • TAYD Industrials
  • Exchange
  • VTYX Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • VTYX 154.9M
  • TAYD 130.2M
  • IPO Year
  • VTYX 2021
  • TAYD N/A
  • Fundamental
  • Price
  • VTYX $2.08
  • TAYD $34.30
  • Analyst Decision
  • VTYX Buy
  • TAYD
  • Analyst Count
  • VTYX 4
  • TAYD 0
  • Target Price
  • VTYX $11.33
  • TAYD N/A
  • AVG Volume (30 Days)
  • VTYX 1.9M
  • TAYD 36.9K
  • Earning Date
  • VTYX 02-25-2025
  • TAYD 01-03-2025
  • Dividend Yield
  • VTYX N/A
  • TAYD N/A
  • EPS Growth
  • VTYX N/A
  • TAYD 27.48
  • EPS
  • VTYX N/A
  • TAYD 2.70
  • Revenue
  • VTYX N/A
  • TAYD $44,486,041.00
  • Revenue This Year
  • VTYX N/A
  • TAYD N/A
  • Revenue Next Year
  • VTYX N/A
  • TAYD N/A
  • P/E Ratio
  • VTYX N/A
  • TAYD $12.50
  • Revenue Growth
  • VTYX N/A
  • TAYD 8.83
  • 52 Week Low
  • VTYX $1.67
  • TAYD $29.26
  • 52 Week High
  • VTYX $11.48
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 45.64
  • TAYD 32.24
  • Support Level
  • VTYX $1.83
  • TAYD $33.05
  • Resistance Level
  • VTYX $2.61
  • TAYD $35.25
  • Average True Range (ATR)
  • VTYX 0.18
  • TAYD 1.73
  • MACD
  • VTYX -0.03
  • TAYD -0.10
  • Stochastic Oscillator
  • VTYX 32.26
  • TAYD 20.06

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: